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Abstract
Background. Despite the well-documented association between smoking and personality
traits such as neuroticism and extraversion, little is known about the potential causal nature
of these findings. If it were possible to unpick the association between personality and smok-
ing, it may be possible to develop tailored smoking interventions that could lead to both
improved uptake and efficacy.
Methods. Recent genome-wide association studies (GWAS) have identified variants robustly
associated with both smoking phenotypes and personality traits. Here we use publicly avail-
able GWAS summary statistics in addition to individual-level data from UK Biobank to inves-
tigate the link between smoking and personality. We first estimate genetic overlap between
traits using LD score regression and then use bidirectional Mendelian randomisation methods
to unpick the nature of this relationship.
Results.We found clear evidence of a modest genetic correlation between smoking behaviours
and both neuroticism and extraversion. We found some evidence that personality traits are
causally linked to certain smoking phenotypes: among current smokers each additional neur-
oticism risk allele was associated with smoking an additional 0.07 cigarettes per day (95% CI
0.02–0.12, p = 0.009), and each additional extraversion effect allele was associated with an ele-
vated odds of smoking initiation (OR 1.015, 95% CI 1.01–1.02, p = 9.6 × 10−7).
Conclusion. We found some evidence for specific causal pathways from personality to smok-
ing phenotypes, and weaker evidence of an association from smoking initiation to personality.
These findings could be used to inform future smoking interventions or to tailor existing
schemes.
Introduction
There is a well-documented association between smoking behaviours and personality traits
such as neuroticism and extraversion (Terracciano and Costa, 2004; Malouff et al., 2006;
Munafò et al., 2007; Hakulinen et al., 2015), and with associated mental health outcomes
such as major depressive disorder (MDD) (Munafò and Araya, 2010; Fluharty et al., 2017).
However, given that much of these data come from observational studies, it is difficult to estab-
lish whether these relationships are causal. It is possible that the observed associations could be
due to confounding, and if a true causal relationship does exist, the direction of effect is
unknown.
Understanding these relationships is important for public health and policy. The World
Health Organisation (WHO) now recognises smoking as one of the leading modifiable risk
factors for disability, disease and death (World Health Organisation, 2002). As a result, if it
were possible to unpick the association between personality and smoking, it may be possible
to develop more tailored smoking interventions, which could lead to both improved uptake
and efficacy. For example, existing smoking cessation schemes could be tailored according
to personality traits (Cherry and Kiernan, 1976), with individuals allocated a different number
of sessions or intensity of intervention according to their level of neuroticism.
Neuroticism and extraversion are two of the main components of personality. The former
reflects emotional instability, stress vulnerability and proneness to anxiety (Kendler et al.,
1993). Higher neuroticism has been linked to anxiety and MDD, with some evidence of shared
genetics and a causal link between neuroticism and MDD onset (Neale et al., 2005; Gale et al.,
2016). Although levels of neuroticism are higher among smokers, the evidence that neuroti-
cism is linked with smoking initiation is inconsistent, with one meta-analysis suggesting
that neuroticism is linked with relapse to smoking among former smokers (Hakulinen
et al., 2015) rather than smoking initiation. In contrast, extraversion is characterised by ten-
dencies such as liveliness and assertiveness of an individual and the level of ease and
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enjoyment of social interactions (Kendler et al., 1993; van den
Berg et al., 2016). There is some suggestion in the literature that
high levels of extraversion are associated with greater rates of
smoking initiation, and lower rates of smoking cessation
(Hakulinen et al., 2015).
With traditional epidemiological methods, it is difficult to
establish causality using observational data due to issues such as
reverse causation and confounding. Mendelian randomisation
(MR) is a technique that enables us to assess causal effects in
observational datasets using genetic instrumental variables (Sallis
et al., 2014). MR can be thought of as analogous to a randomised
controlled trial, with the genetic variants used as proxies or mar-
kers of randomisation into a group that later goes on to encounter
more of a risk factor, such as smoking (Fig. 1). The MR principle
relies on approximations of Mendel’s first and second laws of seg-
regation and independent assortment (Davey Smith, 2011).
Assuming the genetic variants are not associated with the outcome
other than through the risk factor of interest, we can make infer-
ences about the causal direction of any association between the
risk factor and the outcome (Davey Smith and Ebrahim, 2003).
If the underlying assumptions of MR are satisfied, the resulting
effect estimates should be free from the problems of confounding
and reverse causality to which observational epidemiology is prone
(Sallis et al., 2014), although interpretation of such estimates
requires careful consideration (Holmes et al., 2017).
Previous work using MR have yielded no strong evidence of a
causal relationship in the direction of smoking to depression
(Taylor et al., 2014). We therefore hypothesised that if a causal
association with neuroticism exists, it is more likely to act from
neuroticism to smoking. Recent genome-wide association studies
(GWAS) have identified variants robustly associated with a num-
ber of smoking phenotypes (Tobacco and Genetics Consortium,
2010) and with personality traits (Okbay et al., 2016; Lo et al.,
2017). Here we use these publicly available GWAS summary sta-
tistics in addition to individual-level data from UK Biobank
(UKB) (Sudlow et al., 2015) in a bidirectional analysis to investi-
gate whether there appears to be a causal link between smoking
and personality.
Methods and measures
Genetic instruments
Smoking behaviour
Three smoking behaviours were investigated: initiation, heaviness
and cessation. For each of the smoking phenotypes, a single vari-
ant identified by the Tobacco and Genetics (TAG) consortium
(2010) was used as a genetic instrument for this behaviour.
These were as follows: the rs6265 variant in the BDNF gene
identified for smoking initiation, the rs16969968 variant in the
CHRNA5 gene for smoking heaviness among past and current
smokers and the rs3025343 variant in the DBH gene for smoking
cessation. For each phenotype, the effect allele was that which cor-
responded to an increase in the relevant smoking behaviour.
Personality
Eleven independent variants associated with neuroticism were
reported by Okbay et al. (2016). Of the original variants, five of
these were unavailable in the TAG smoking data. Proxies were
identified for four of these single-nucleotide polymorphisms
(SNPs) using SNIPA (Arnold et al., 2015) (r2 > 0.85). A complete
list of variants included in the neuroticism instrument can be
found in online Supplementary Table S1. Five independent var-
iants associated with extraversion were identified using data
from the Genetics of Personality Consortium (GPC) and
23andMe (Lo et al., 2017). Of these variants, three variants
were unavailable in the TAG summary statistics. Using SNIPA,
we identified a proxy for one of these variants (online
Supplementary Table S1). There was no overlap between the var-
iants included in any of the smoking or personality instruments.
The amount of variance explained by each of these instru-
ments in UKB is reported in online Supplementary Table S2.
Data sources
Summary statistics from several GWASs were used for two-sample
MR analyses, while individual-level data from UKB were used for
one-sample analyses.
GWAS summary statistics
Publicly available summary statistics are available for recent
genome-wide analyses of both smoking phenotypes and personal-
ity traits. GWAS summary statistics for smoking initiation, cessa-
tion and heaviness were published by the TAG consortium
(2010). Summary statistics for personality traits were taken from
two recent GWASs of neuroticism and extraversion (Okbay
et al., 2016; Lo et al., 2017).
UK Biobank
UKB has collected phenotypic information on around 500 000
participants, with genotyping available on approximately 337
106 unrelated Europeans, exclusion criteria and quality control
measures are described in detail elsewhere (Bycroft et al., 2017;
Mitchell et al., 2017). An interim release of genetic data was
made available in 2015 for a subset of the cohort. This subset
was included in the neuroticism GWAS and contained approxi-
mately 114 780 European individuals (Sudlow et al., 2015).
Fig. 1. Directed acyclic graph illustrating Mendelian randomisation.
In this model, allelic risk scores associated with neuroticism are cal-
culated and used to assess the association of neuroticism with
smoking heaviness.
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Smoking status was defined as ever (consisting of current and
former smokers) or never smoker according to responses given at
the initial assessment visit in UKB. Smoking heaviness was
derived for former and current smokers based on responses to
‘number of cigarettes currently smoked daily’ at the initial assess-
ment. For former smokers, this question related to number of
cigarettes previously smoked on a daily basis.
Neuroticism scores were derived from a number of neurotic
behaviour domains measured at the initial assessment visit.
These scores were externally derived by Smith et al. (2013) and
are available for use by researchers accessing the UKB resource.
Scores range from 0 to 12 with a higher score corresponding to
a greater number of neurotic behaviours. There was no direct
measure of extraversion in UKB, so analyses of this trait were
restricted to those using the genetic instrument for extraversion.
Unweighted polygenic risk scores for neuroticism and extra-
version were calculated for each individual in UKB based on
the number of copies of each risk allele carried by an individual;
this ranged from 0 to 2 for each SNP. The neuroticism risk score
ranged from 1 to 19 and corresponded to the number of neuroti-
cism increasing alleles per individual. A risk score was calculated
similarly for extraversion and ranged from 0 to 6. Although
weighted scores can give a more precise effect estimate, the neur-
oticism GWAS included the interim release of UKB within the
discovery sample (Okbay et al., 2016; Wray et al., 2018). Risk
scores should use weightings derived from independent samples
to avoid introducing bias into the effect estimates (Hartwig and
Davies, 2016).
Statistical analysis
Genetic correlation
In a first step, GWAS summary statistics were used to estimate the
genetic correlation of smoking initiation with both neuroticism
and extraversion. LD score regression was performed (without
constraining the intercept) using the GWAS summary statistics
to assess the amount of genetic overlap between the two traits.
In order to estimate genetic correlation between personality mea-
sures and additional smoking phenotypes of smoking heaviness
and cessation, summary statistics for the personality GWAS
would need to be stratified by smoking status. Although the ori-
ginal GWAS summary statistics were not available stratified by
smoking status, it was possible to estimate these genetic correla-
tions using the individual-level data available in UKB. Genome-
wide complex trait analysis (GCTA) software (Yang et al., 2011)
was used to estimate genetic correlation for each smoking
phenotype using data from UKB.
Two-sample MR using summary statistics
Bidirectional two-sample MR analyses were performed using the
genetic instruments described above. Effect estimates and standard
errors (S.E.s) were extracted for each variant from the relevant
GWAS results and used to estimate inverse variance weighted
(IVW) effect estimates. For the neuroticism instrument which
incorporated multiple SNPs, we performed a number of sensitivity
analyses. Effect estimates and S.E.s were extracted from the original
GWAS results as described above and MR-Egger (Bowden et al.,
2015) and weighted median regression (Bowden et al., 2016)
approaches were performed. These are complementary
approaches: MR-Egger calculates effect estimates adjusted for hori-
zontal pleiotropy (under the assumption that other conditions of
MR-Egger are not violated) (Bowden et al., 2015), while weighted
median calculates effects which are robust as long as 50% or more
of the statistical weight within an analysis comes from valid instru-
ments (Bowden et al., 2016). We also calculated Rücker’s Q to
investigate heterogeneity in the SNP-exposure associations
(Bowden et al., 2017). Neuroticism and extraversion GWAS results
were not stratified by smoking status. As a result, when using sum-
mary statistics, analyses in the direction of smoking to personality
were restricted to smoking initiation only.
One-sample analyses using individual-level data
Further analyses were performed using data from UKB. These
analyses estimated the association between the genetic instrument
and the outcome as there was no measure of extraversion in
the UKB sample, and the neuroticism GWAS included data
from UKB which could bias the two-sample IVW estimates.
Within UKB, it was possible to stratify participants according to
smoking status. Therefore, in addition to smoking initiation, we
also investigated the association between both smoking heaviness
and cessation with personality. These analyses were adjusted for
the top 10 principal components as well as genotype array.
Sensitivity analyses
We restricted analyses using the neuroticism risk score to partici-
pants who were not included in the interim release of the genetic
data, and who were therefore not included in the discovery sam-
ple. We also calculated IVW estimates in UKB using the neuroti-
cism instrument for comparison with the effect estimates from the
two-sample analysis.
Results
Genetic correlation
LD score regression using summary statistics from the TAG con-
sortium GWAS of smoking initiation and the Okbay et al. neur-
oticism GWAS suggested evidence of a modest genetic correlation
between the two traits (rG = 0.124, S.E. = 0.05, p = 0.008). There
was also evidence of a larger genetic correlation between extraver-
sion and smoking initiation (rG = 0.288, S.E. = 0.01, p = 0.001;
Table 1). We used GCTA software to calculate genetic correlation
using individual-level data from UKB. There was evidence of gen-
etic correlation between neuroticism and smoking heaviness
among both current (rG = 0.248, S.E. = 0.12, p = 0.013) and former
smokers (rG = 0.220, S.E. = 0.06, p = 1.8 × 10
−5). We found evi-
dence of a negative genetic correlation between smoking cessation
and neuroticism (rG =−0.314, S.E. = 0.15, p = 0.002; Table 1).
Observational association between neuroticism and smoking
behaviours
Data on smoking status and neuroticism were available from UKB.
A total of 389 770 participants had data available on both smoking
and neuroticism, with genotyping available on 273 516 of these
after applying QC measures. There was strong evidence of an
observational association between neuroticism and smoking status
in both the entire UKB sample and when restricting to those with
genotyping data. Mean neuroticism scores were higher among
former (4.22, S.D. = 3.3) and current smokers (4.66, S.D. = 3.5)
than non-smokers (3.89, S.D. = 3.2, p < 0.001). We found evidence
of an association between neuroticism and cigarettes smoked per
day with heavier smokers reporting higher neuroticism scores
(β = 0.02, 95% CI 0.02–0.03, p < 0.001).
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Effects of smoking on personality traits
Neuroticism
We first used two-sample MR to investigate the effect of smoking
initiation on personality using publicly available GWAS summary
statistics. This found no clear evidence of an effect of smoking ini-
tiation on neuroticism when using rs6265 as an instrument for
smoking initiation (β =−0.032, 95% CI −0.16 to 0.09, p = 0.617;
Table 2). A one-sample approach was also used to investigate
the association between each smoking behaviour and neuroticism
in UKB. This found weak evidence of an effect, with each copy of
the smoking initiation risk allele associated with a lower neuroti-
cism score (β =−0.023, 95% CI −0.045 to −0.001, p = 0.037;
Table 2).
The genetic variant rs16969968 was used as a proxy for smok-
ing heaviness in UKB. Despite strong evidence of an observational
association between smoking heaviness and neuroticism, we
found no robust evidence of a causal effect of the rs16969968 vari-
ant for smoking heaviness on neuroticism among either former or
current smokers (Table 2). Using the rs3025343 variant as a proxy
for smoking cessation found no strong evidence of an effect of
smoking cessation on neuroticism (β = 0.029, 95% CI −0.01 to
0.07, p = 0.161; Table 2) in UKB.
Extraversion
When using two-sample MR to look at the association between
extraversion and smoking, there was some indication that smok-
ing initiation was associated with greater extraversion (β = 0.198,
95% CI −0.03 to 0.42, p = 0.084; Table 2), although the evidence
for this was weak. There was no relevant measure of extraversion
in UKB, so we were unable to look at the effect of the genetic vari-
ant for smoking initiation on extraversion using individual-level
data.
Effects of personality traits on smoking
Smoking initiation
Two-sample MR using summary statistics found no clear evi-
dence for an effect of neuroticism on smoking initiation either
when using an IVW approach (OR 1.165, 95% CI 0.71–1.91,
p = 0.499; Table 3) or when performing sensitivity analyses
(online Supplementary Tables S3 and S4). Among the UKB par-
ticipants, there was no robust evidence for an effect of the neur-
oticism risk score on smoking initiation (OR 1.000, 95% CI
0.997–1.003, p = 0.980; Table 3). When looking at the effect of
extraversion on smoking initiation, we found no strong evidence
of an effect when using a two-sample approach (OR 1.733, 95%
CI 0.37–8.23, p = 0.268). However, this may be due to a lack of
power. The direction of effect was consistent within the UKB
sample, where there was strong evidence of an association. Each
additional extraversion allele was associated with 1.5% higher
odds of ever smoking (OR 1.015, 95% CI 1.01–1.02, p = 9.6 ×
10−7; Table 3).
Smoking heaviness
Using an IVW approach, we found no clear evidence for an effect
of neuroticism on smoking heaviness (β = 0.050, 95% CI −4.11 to
4.21, p = 0.979; Table 3). However, MR-Egger suggested some evi-
dence of horizontal pleiotropy (β =−0.500, 95% CI −0.93 to
−0.07, p = 0.026; online Supplementary Tables S3 and S4) and
the bias-adjusted estimate suggested some evidence of an associ-
ation between neuroticism and greater smoking heaviness (β =
22.55, 95% CI 2.82–42.27, p = 0.027). We also looked at this asso-
ciation in UKB when stratifying according to smoking status and
found some evidence of an association. Among current smokers,
the neuroticism risk score was associated with greater smoking
heaviness (β = 0.068, 95% CI 0.02–0.12, p = 0.009; Table 3). In
this analysis, each additional neuroticism risk allele was associated
with smoking an extra 0.07 cigarettes per day. We found no
robust evidence for an effect of extraversion on smoking heaviness
either when using a two-sample MR approach (β = 0.017, 95% CI
−16.33 to 16.37, p = 0.997; Table 3) or when stratifying on smok-
ing status and investigating this association in UKB. This
remained the case among both former (β =−0.021, 95% CI
−0.08 to 0.04, p = 0.519) and current smokers (β = −0.038, 95%
CI −0.13 to 0.05, p = 0.419; Table 3).
Smoking cessation
When using two-sample MR with summary statistics, we found
no robust evidence for an effect of neuroticism on smoking cessa-
tion when using the IVW approach, or when performing sensitiv-
ity analyses (Table 3, online Supplementary Tables S3 and S4).
This remained the case when looking within UKB (OR 0.997,
95% CI 0.99–1.00, p = 0.272; Table 3). There was no strong evi-
dence for an effect of extraversion on smoking cessation when
using two-sample MR with summary statistics (OR 0.586, 95%
CI 0.07–4.76, p = 0.387; Table 3). When restricting our analyses
to current and former smokers within UKB, we found weak evi-
dence of an effect and the direction of effect was consistent with
that shown in the two-sample analysis. Each additional increase in
extraversion risk allele was associated with 1.1% lower odds of
smoking cessation (95% CI 0.98–1.00, p = 0.057; Table 3).
Sensitivity analyses
Analyses involving neuroticism were also performed restricting to
participants whose genetic data were not included in the interim
release of UKB data. Full results are reported in online
Supplementary Table S5. Results remained largely consistent
with those calculated in the full sample. In this subset, the
strength of evidence for the effect of neuroticism on smoking
heaviness was weakened (current smokers: β = 0.053, 95% CI
−0.01 to 0.12, p = 0.120). However, the effect size remained con-
sistent, so this may be due to a lack of power in this smaller
sample.
IVW effect estimates were calculated for the effect of neuroti-
cism on smoking behaviours using the full release of UKB (online
Table 1. Genetic correlation between smoking phenotypes and personality
traits using GWAS summary statistics and individual-level data from UK Biobank
rG (S.E.) p value
Neuroticism and smoking initiationa 0.124 (0.05) 0.008
Extraversion and smoking initiationa 0.288 (0.01) 0.001
Neuroticism and smoking heaviness
(current smokers)b
0.248 (0.12) 0.013
Neuroticism and smoking heaviness
(former smokers)b
0.220 (0.06) 1.8 × 10−5
Neuroticism and smoking cessationb −0.314 (0.15) 0.002
aGenetic correlation estimates for smoking initiation were generated using GWAS summary
statistics.
bEstimates for smoking heaviness and cessation were generated using individual-level data
from UK Biobank.
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Supplementary Table S6). The effect estimates are consistent with
those from the two-sample MR and the one-sample analyses. We
find no robust evidence of an association with either smoking ini-
tiation or cessation, but strong evidence of an association between
neuroticism and increased smoking heaviness.
Power calculations
We performed power calculations for the two-sample MR ana-
lyses. Assuming that the genetic instrument for personality traits
explains around 1% of the variation in the exposure and that our
sample comprises of around 50% ever smokers, our sample had
approximately 86% power to detect 25% greater odds of smoking
initiation per each S.D. increase in personality trait. We had
around 83% power to detect a change of 0.15 cigarettes per day
or 25% lower odds of smoking cessation per S.D. increase in per-
sonality trait.
Discussion
We attempted to disentangle the relationship between smoking
and the personality traits of neuroticism and extraversion. We
found evidence of a modest genetic correlation with both neuroti-
cism and extraversion, which could indicate a causal pathway
between personality and smoking behaviours. However, it is not
clear in which direction this pathway acts, and there are also alter-
native explanations such as horizontal pleiotropy (direct genetic
effects on multiple traits) (Davey Smith and Hemani, 2014). We
used one- and two-sample MR analyses to investigate these path-
ways in more detail.
Given that available GWAS summary statistics for neuroticism
and extraversion are not stratified by smoking status, we initially
used two-sample MR approaches to look at the bidirectional asso-
ciation with smoking initiation. This was followed by one-sample
analyses using individual-level data from UKB, in instances where
these data were available. When looking at the effect of smoking
on personality, we found weak evidence that the rs6265 variant
for smoking initiation was associated with both lower neuroticism
and higher extraversion. When looking in the reverse direction,
evidence was stronger. We found some evidence that each add-
itional neuroticism effect allele was associated with smoking an
additional 0.07 cigarettes per day, and that each additional extra-
version effect allele was associated with 1.5% greater odds of ever
smoking. There was also some suggestion that the extraversion
risk score was associated with lower smoking cessation, although
the evidence for this was weak.
Estimates from both two-sample MR and one-sample analyses
in UKB found a consistent direction of effect, with the smoking
initiation instrument (rs6265) associated with a reduction in
neuroticism scores, although the evidence for this was weak across
both analyses. Although this is a strong instrument for smoking
initiation, there could be potential horizontal pleiotropic effects.
A recent GWAS investigating risk-taking behaviours used a multi-
trait analysis of GWAS approach and identified the rs6265 variant
as a lead SNP associated with general-risk-tolerance (Linnér et al.,
2018). One approach to reduce the potential impact of these
effects could be to identify additional strongly associated, but
independent variants to include in the smoking initiation instru-
ment by relaxing the p value threshold used to select instruments
from the original GWAS, as all horizontal pleiotropic effects
would need to operate in the same direction (Gage et al., 2017).
Analyses from personality to smoking behaviours found some
evidence of an association between higher neuroticism and smok-
ing heaviness using one-sample MR and two-sample MR after
adjusting for horizontal pleiotropy. Both the observational and
MR analyses found a stronger effect among current smokers.
These findings are consistent with the self-medication hypothesis
(Khantzian, 1985, 1997), and in line with previous literature, such
as a twin study by Kendler et al. which identified an association
with smoking and nicotine dependence (Kendler et al., 1999). It
is also possible that this pathway is causal only among smokers
who find it hard to quit. Observationally, we see higher levels
Table 2. Effect of smoking on personality traits using one- and two-sample MR
Exposure Outcome Sample Instrument
Smoking
status βa 95% CI
p
value N
Smoking
initiation
Neuroticism GWAS
summary
statistics
rs6265 All −0.032 −0.16 to 0.09 0.617 170.911
UK Biobank All −0.023 −0.045 to −0.001 0.037 274 230
Extraversion GWAS
summary
statistics
rs6265 All 0.198 −0.03 to 0.42 0.084 63 030
UK Biobank – – – –
Smoking
heaviness
Neuroticism UK Biobank Non-smokers 0.004 −0.02 to 0.03 0.745 149 960
Former
smokers
0.011 −0.02 to 0.04 0.472 96 674
Current
smokers
0.038 −0.02 to 0.10 0.234 26 882
Smoking
cessation
Neuroticism UK Biobank Non-smokers 0.004 −0.03 to 0.04 0.822 149 960
Ever smokers 0.029 −0.01 to 0.07 0.161 123 556
aTwo-sample results reported using GWAS summary statistics refer to the causal effect of smoking behaviour on a personality trait. UK Biobank results are effect sizes of the genetic variants
for smoking behaviours on personality traits.
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of neuroticism among current smokers and stronger evidence of a
genetic correlation among this subgroup of individuals, the diver-
gent effects shown in the one-sample MR would be consistent
with this interpretation. However, if both neuroticism and smok-
ing heaviness are associated with difficulty in quitting, then it is
possible that this association is due to collider bias. These findings
could be used to inform existing smoking cessation services, with
the type or intensity of intervention tailored according to an indi-
vidual’s level of neuroticism.
We also observed some evidence of an association between
extraversion and smoking. Unlike neuroticism, extraversion did
not show evidence of a causal relationship with smoking heavi-
ness, but we did find an association with smoking initiation.
Although there was no strong evidence of an association when
using a two-sample approach, this could be due to a lack of
power given that the direction of effect was consistent with that
observed in UKB. Using UKB data, there was evidence that indi-
viduals with a higher genetic liability for extraversion had greater
odds of taking up smoking. One potential mechanism for this is
that extraversion could lead to more social contacts and greater
susceptibility to peer influences, which are known to be important
in smoking initiation (Kobus, 2003; Haas and Schaefer, 2014).
These findings could be used to improve existing smoking preven-
tion schemes, for example, tailoring the messages and images
used in health warnings.
There are a number of limitations to our analysis that should
be considered. First, UKB formed a large part of the discovery
cohort for the GWAS of neuroticism. We were therefore unable
to use weighted risk scores to assess the association between
smoking phenotypes and neuroticism in our one-sample analyses
– weights should be identified in independent samples to avoid
overfitting the data and introducing bias into effect estimates
Table 3. Effect of personality traits on smoking using one- and two-sample MR
Exposure Outcome Sample Instrument
Smoking
status ORa 95% CI p value N
Neuroticism Smoking
initiation
GWAS
summary
statistics
IVW All 1.165 0.71–1.91 0.499 74 035
UK Biobank Unweighted
score
All 1.000 0.997–1.003 0.980 318 985
Extraversion Smoking
initiation
GWAS
summary
statistics
IVW All 1.733 0.37–8.23 0.268 74 035
UK Biobank Unweighted
score
All 1.015 1.01–1.02 9.6 × 10−7 332 596
βa 95% CI p value N
Neuroticism Smoking
heaviness
GWAS
summary
statistics
IVW Ever
smokers
0.050 −4.11 to 4.21 0.979 38 181
UK Biobank Unweighted
score
Former
smokers
−0.018 −0.05 to 0.02 0.315 70 909
Current
smokers
0.068 0.02–0.12 0.009 21 449
Extraversion Smoking
heaviness
GWAS
summary
statistics
IVW Ever
smokers
0.017 −16.33 to 16.37 0.997 38 181
UK Biobank Unweighted
score
Former
smokers
−0.021 −0.08 to 0.04 0.519 73 967
Current
smokers
−0.038 −0.13 to 0.05 0.419 22 340
ORa 95% CI p value N
Neuroticism Smoking
cessation
GWAS
summary
statistics
IVW Ever
smokers
0.797 0.43–1.47 0.423 41 278
UK Biobank Unweighted
score
Ever
smokers
0.997 0.99–1.00 0.272 144 119
Extraversion Smoking
cessation
GWAS
summary
statistics
IVW Ever
smokers
0.586 0.07–4.76 0.387 41 278
UK Biobank Unweighted
score
Ever
smokers
0.989 0.98–1.00 0.057 150 294
aTwo-sample results reported using GWAS summary statistics refer to the causal effect of personality traits on smoking behaviours. UK Biobank results are effect sizes of the genetic
instruments for personality traits on smoking behaviours.
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(Hartwig and Davies, 2016). However, we performed sensitivity
analyses restricting to individuals who were not included in the
discovery samples as well as estimating IVW estimates, and results
remained consistent. Second, we were unable to use two-sample
methods to assess the association from smoking heaviness and
cessation to neuroticism and extraversion because the personality
summary statistics were not stratified by smoking status. However,
we did investigate the association in both directions for neuroti-
cism when using the UKB data. Both the two-sample and UKB
analyses gave consistent results when looking at the neuroticism
to smoking initiation relationship. Third, due to the lack of an
extraversion phenotype currently available in UKB, we were
unable to investigate whether there was evidence of an effect
from smoking to extraversion. Fourth, MR analyses can often suf-
fer from a lack of power, with large sample sizes and strong
instruments required to detect effects. We have identified genetic
variants robustly associated with each trait of interest based on
results of large recently published GWAS in order to maximise
the strength of our instruments. In this analysis, we have triangu-
lated our findings using a combination of one- and two-sample
MR approaches to maximise our power to detect any effect
(Lawlor et al., 2017). Fifth, we stratified on smoking status to
investigate the association of smoking heaviness and cessation
phenotypes. Although this allows us to investigate pleiotropy,
there is the potential to introduce collider bias when stratifying
on an exposure (Munafò et al., 2018). However, in these stratified
analyses, our instruments are principally associated with smoking
heaviness and cessation rather than smoking status, so that the
risk of collider bias is minimised (Gage et al., 2016).
In conclusion, we found evidence of modest genetic correl-
ation between smoking behaviour and both neuroticism and
extraversion. We found some evidence for specific causal path-
ways from personality to smoking phenotypes – from higher
neuroticism to heavier cigarette consumption, and from higher
extraversion to greater odds of smoking initiation. Evidence in
the alternative direction, suggesting that smoking behaviour influ-
ences personality, was weaker. These findings could be used to
inform future smoking interventions, for example, tailoring exist-
ing smoking cessation schemes to provide people with high or low
neuroticism a different type or intensity of service.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291718003069.
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